- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0017906

Xenomics Pharmaceuticals Private Limited
About Xenomics Pharmaceuticals Private Limited
Data last updated:
Xenomics Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 10 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2021PTC148581.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shiva Raj Gandla (Managing Director) and Padma Gandla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Syno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.71 Lakh, a growth of 53% compared to the previous year. For the same year it recorded a net loss of ₹19,571 (net margin -0.4%) and EBITDA of ₹1.62 Lakh (EBITDA margin 3.3%).
The company has about 7 employees on its provident fund (EPFO) records.
Xenomics Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0017906).
Company details
Recognitions & Rankings of Xenomics Pharmaceuticals
Contact details
Xenomics Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressSyno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xenomics Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xenomics Pharmaceuticals Private Limited, buy the company report.
Financials of Xenomics Pharmaceuticals Private Limited
FY 2024 filings availableXenomics Pharmaceuticals Private Limited reported revenue of ₹49.71 Lakh (up 53% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 53% in the latest year. EBITDA rose 119% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.62 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹19,571 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.3% | |||
| Net Profit Margin | -0.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Xenomics Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xenomics Pharmaceuticals Private Limited
Xenomics Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiva Raj Gandla | Managing Director | 10 Feb 2021 | 5 Years 9 Months | Current |
| Padma Gandla | Director | 10 Feb 2021 | 5 Years 9 Months | Current |
Peer comparison
Xenomics Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unique Medicare Private Limited | ₹49.8 Lakh (FY 2025) | 127.0% | New Delhi, Delhi, India | |||
| Oxygen Life Care Private Limited | ₹49.74 Lakh (FY 2024) | -25.0% | Howrah, West Bengal, India | |||
| Sunrise Mediworld Private Limited | ₹49.72 Lakh (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| Xenomics Pharmaceuticals Private Limitedthis company | ₹49.71 Lakh (FY 2024) | -₹19,571 | -0.4% | 53.0% | Hyderabad, Telangana, India | |
| Laurel Healthcare Private Limited | ₹49.69 Lakh (FY 2025) | -12.0% | Dehradun, Uttarakhand, India | |||
| Vancorp Pharmaceuticals Private Limited | ₹49.64 Lakh (FY 2025) | 3.0% | Gautam Budh Nagar, Uttar Pradesh, India | |||
| Reinheit Pharmaceuticals Private Limited | ₹49.48 Lakh (FY 2024) | 132.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Xenomics Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xenomics Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xenomics Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Xenomics Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Xenomics Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Padma Gandla was appointed as Director on 10 Feb 2021.
Frequently asked questions
Xenomics Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 10 February 2021 (5+ years old) and is registered under CIN U51909TG2021PTC148581.
Xenomics Pharmaceuticals has 2 current directors:
- Shiva Raj Gandla - Managing Director
- Padma Gandla - Director
The latest financial statements of Xenomics Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Xenomics Pharmaceuticals is U51909TG2021PTC148581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xenomics Pharmaceuticals was incorporated on 10 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Xenomics Pharmaceuticals by revenue are Unique Medicare Private Limited, Oxygen Life Care Private Limited, Sunrise Mediworld Private Limited, Laurel Healthcare Private Limited, Vancorp Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Padma Gandla was appointed as Director on 10 Feb 2021. Shiva Raj Gandla was appointed as Managing Director on 10 Feb 2021.
Yes, Xenomics Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0017906).
The registered office of Xenomics Pharmaceuticals is at Syno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009.
Xenomics Pharmaceuticals operates in the trading industry, in the specialty segment.
Xenomics Pharmaceuticals can be reached at its registered office: Syno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009.

